EU Commissioners failed to reach agreement on approval or disapproval of a dozen pending biotech traits. The fact that politics rather than science largely drives EU debate on the topic is revealed in two ways. Biotech in EU and U.S. EU Commissioners failed to reach agreement on approval or disapproval of a dozen pending biotech traits, and further action appears stalled until after issuance of a GMO policy review paper at the end of April. The fact that politics rather than science largely drives EU debate on the topic is revealed in two ways: 1) Commissioners discussed the need to address public perceptions on biotech food; and 2) they discussed which traits to even consider for importation based on their economic impacts to European ag...